A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for
Month: November 2020
First drug for rare rapid-aging disease extends kids’ lives
The first drug was approved Friday for a rare genetic disorder that stunts growth and causes rapid aging in children,
Superspreader events key driver in COVID-19 pandemic
At churches, on cruise ships and even in the White House, superspreading events that can sicken dozens, even hundreds, of
Researchers examine which approaches are most effective at reducing COVID-19 spread
Simon Fraser University professors Paul Tupper and Caroline Colijn have found that physical distancing is universally effective at reducing the
New non-invasive technology could spot early signs of motor disorders in babies
The research, carried out using a wearable cuff, provides a new method for monitoring movements in babies, and new insights
Gut immune cells may help send multiple sclerosis into remission
An international research team led by UCSF scientists has shown, for the first time, that gut immune cells travel to
Study: Tuberculosis vaccine linked to lower risk of contracting COVID-19
A widely used tuberculosis vaccine is associated with reduced likelihood of contracting COVID-19 (coronavirus), according to a new study by
Discovery illuminates how cell growth pathway responds to signals
A basic science discovery by researchers at the Johns Hopkins Bloomberg School of Public Health reveals a fundamental way cells
Food health star ratings can improve diets, study finds
More evidence has emerged that food labelling can encourage manufacturers to improve product nutrition, but University of Melbourne experts say
Frequent, rapid testing could cripple COVID within weeks, study shows
Testing half the population weekly with inexpensive, rapid-turnaround COVID-19 tests would drive the virus toward elimination within weeks— even if
